StonvexLoading…
StonvexCore line items from CLFD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Annual 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $44.80M | $68.73M | $34.34M | $150.13M | $132.55M |
Operating Income | Not available | $-3.89M | $-1.82M | $2.12M | $-2.22M |
Net Income | Not available | $-1.14M | $-614.00K | $-8.05M | $1.03M |
EPS (Diluted) | $0.19 | $-0.08 | $-0.04 | $-0.58 | $0.07 |
Total Assets | Not available | $263.55M | $268.05M | $306.17M | $314.71M |
Total Liabilities | Not available | $20.74M | $18.40M | $50.01M | $50.23M |
Cash & Equivalents | Not available | $9.40M | $13.88M | $21.49M | $33.87M |
Free Cash Flow OCF − CapEx | Not available | $-4.52M | $-2.43M | $21.81M | $13.64M |
Shares Outstanding | Not available | 13.62M | 13.84M | 13.84M | 13.81M |